Management of diarrhoea in HIV-infected patients

International Journal of STD and AIDS

Volumn 12, Issue 10, 2001, Pages 630-639

  Mitra, A K ^a   Hernandez, C D ^a   Hernandez, C A ^a   Siddiq, Z ^a  

^a UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

Author keywords

AIDS; Diarrhoea; HIV; HIV enteropathy; Treatment

Indexed keywords

ACICLOVIR; ALBENDAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CIDOFOVIR; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DAPSONE; ETHAMBUTOL; FAMCICLOVIR; FLUCONAZOLE; FLUCYTOSINE; FOLINIC ACID; FOSCARNET; GANCICLOVIR; ITRACONAZOLE; KETOCONAZOLE; METRONIDAZOLE; NYSTATIN; PAROMOMYCIN; PIVMECILLINAM; PYRIMETHAMINE; VALACICLOVIR; VANCOMYCIN;

BACTERIAL INFECTION; CLINICAL FEATURE; CRYPTOSPORIDIUM; CYTOMEGALOVIRUS; DIAGNOSTIC VALUE; DIARRHEA; ENTEROPATHY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MICROSPORA; MYCOBACTERIUM; MYCOSIS; OPPORTUNISTIC INFECTION; PARASITOSIS; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; VIRUS INFECTION;

DIARRHEA; HIV INFECTIONS; HUMANS; OPPORTUNISTIC INFECTIONS;

EID: 0034788091     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011923840     Document Type: Review

References (65)

1. Diagnosis and management of AIDS-related diarrhea
2. AIDS enteropathy
3. Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum
4. Enteropathy associated with the acquired immunodeficiency syndrome
5. Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory diarrhea. Effects of treatment with octreotide
6. Gastrointestinal symptoms in patients infected with human immunodeficiency virus: Relevance of infective agents isolated from gastrointestinal tract
7. Viral infections in human immunodeficiency virus disease
8. Esophageal ulceration in human immunodeficiency virus infection. Causes, response to therapy and long-term outcome
9. Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus
10. Enteric viruses and diarrhea in HIV-infected patients
11. Nontuberculosis mycobacterial infections
12. Pneumocystis colitis in a patient with the acquired immunodeficiency syndrome
13. Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients
14. Persistent diarrhoea in Zairian AIDS patients: An endoscopic and histological study
15. The microbial causes of diarrhoea in patients with the human immunodeficiency virus
16. Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire
17. Persistent diarrhea associated with AIDS
18. Clinical patterns of diarrhea in AIDS: Etiology and prognosis
19. Cryptosporidiosis in HIV-seropositive patients
20. Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: Prevalence and clinical and biologic features
21. Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: A report of 20 cases
22. Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome
23. Cryptosporidium infection in acquired immunodeficiency syndrome: Not always a poor prognosis
24. Intestinal parasites in patients with diarrhea and human immunodeficiency virus infection in Zimbabwe
25. Blastocystosis: A new disease in the acquired immunodeficiency syndrome?
26. High prevalence of Enterocytozoon bieneusi infections among HIV-positive individuals with persistent diarrhoea in Harare, Zimbabwe
27. Cyclospora infection in adults infected with HIV: Clinical manifestations, treatment, and prophylaxis
28. Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: Clinical, microbiologic and epidemiologic features
29. Clostridium difficile-associated diarrhea in patients with HIV positivity and AIDS: A prospective controlled study
30. Hep-2 cell-adherent Escherichia coli in patients with human immunodeficiency virus-associated diarrhea
31. Gastrointestinal manifestations of HIV infection
32. Potentially lethal complications of shigellosis
33. Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients
34. Oral Candida in HIV infection and AIDS: New perspectives/new approaches
35. Gastrointestinal disease
36. USPHS/IDSA guidelines for the prevention of opportunistic infections in person infected with human immunodeficiency virus: An overview
37. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms
38. Clinical and epidemiologic features of a massive waterborne outbreak of cryptosporidiosis in persons with HIV infection
39. Effect of human immunodeficiency virus on local immunity in children with diarrhoea
40. Absence of an association between enteric parasites in the manifestations and pathogenesis of HIV enteropathy in gay men
41. Jejunal mucosal architecture and fat absorption in male homosexuals infected with human immunodeficiency virus
42. Jejunal biopsy in HIV-infected patients
43. D-xylose malabsorption: Characteristic finding in patients with the IDS wasting syndrome and chronic diarrhea
44. Malnutrition and carbohydrate malabsorption in children with vertically transmitted human immunodeficiency virus 1 infection
45. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea
46. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: A double-blind, controlled clinical trial
47. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients
48. Treatment of non-HIV cryptosporidial diarrhea with azithromycin
49. Nitrozoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency in tropical Africa
50. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS
51. Treatment of intestinal microsporidiosis with albendazole in patients with AIDS
52. Pivmecillinam-resistant Shigella dysenteriae type 1 infection in Bangladesh
53. Emergence of antimicrobial-resistant shigellosis in Oregon
54. Antimicrobial susceptibility and presence of extrachromosomal deoxyribonucleic acid in Salmonella and Shigella isolates from patients with AIDS
55. Plasmid analysis of Shigella dysenteriae type 1 isolates obtained from widely scattered geographical locations
56. Antimicrobial therapy for shigellosis
57. Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms
58. Efficacy of octreotide in the management of chronic diarrhoea in AIDS
59. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial
60. Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhoea. Effects of treatment with octreotide
61. Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: A randomized crossover study
62. Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea
63. A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS
64. Treating malnutrition in AIDS: Comparison of dietitians' practices and nutrition care guidelines
65. Vitamin C: A new look